![]() |
![]() |
Legal status
Patent in force
(51) | INT.CL. | A61P 39/00 | (2006.01) |
A61P 35/00 | (2006.01) | ||
A61K 47/68 | (2017.01) |
(11) | Number of the document | 2906298 |
(13) | Kind of document | T |
(96) | European patent application number | 13785831.2 |
Date of filing the European patent application | 2013-10-11 | |
(97) | Date of publication of the European application | 2015-08-19 |
(45) | Date of publication and mention of the grant of the patent | 2018-10-03 |
(46) | Date of publication of the claims translation | 2018-12-27 |
(86) | Number | PCT/EP2013/071346 |
Date | 2013-10-11 |
(87) | Number | WO 2014/057117 |
Date | 2014-04-17 |
(30) | Number | Date | Country code |
201261712924 P | 2012-10-12 | US | |
201261712928 P | 2012-10-12 | US | |
201361784421 P | 2013-03-14 | US | |
201361784362 P | 2013-03-14 | US | |
201361784383 P | 2013-03-14 | US |
(72) |
VAN BERKEL, Patricius Hendrikus Cornelis, CH
HOWARD, Philip Wilson, GB
|
(73) |
Medimmune Limited,
Milstein Building Granta Park, Cambridge, Cambridgeshire CB21 6GH,
GB
ADC Therapeutics SA, Route de la Corniche 3B, 1066 Epalinges, CH |
(74) |
Jurga PETNIŪNAITĖ,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
(54) | Pirolbenzodiazepino-antikūno konjugatai |
PYRROLOBENZODIAZEPINE-ANTIBODY CONJUGATES |
Payment date | Validity (years) | Amount | |
2024-09-19 | 12 | 289.00 EUR |
2025-10-11 |